Le Lézard
Classified in: Health, Covid-19 virus
Subject: AVO

Major Groups Representing Millions of Patients Release Telehealth Principles


WASHINGTON, Sept. 24, 2020 /PRNewswire/ -- A coalition of organizations representing millions of patients who live with serious, acute, and chronic conditions has released principles to guide policymakers seeking to ensure patients can continue to safely access appropriate telehealth services during and after the COVID-19 public health emergency.

Telehealth has long been an important care delivery method for improving access in underserved and rural communities, which often face physician shortages, and areas with limited access to primary care services. However, the COVID-19 pandemic has highlighted the critical role telehealth can play in helping all patients continue to receive timely and safe health care services and treatments from their providers.

At the start of the COVID-19 pandemic, federal and state agencies provided new, and in some cases time-limited, flexibilities to increase access to telehealth. This has allowed millions of patients to access necessary health care services from the comfort and safety of their homes, driving an exponential increase in telehealth utilization. The coalition believes telehealth can and should be used to increase patient access to care. To permanently integrate it into the US health care system and ensure its integration drives the best care possible, new legislation and regulation will be necessary.

To ensure access, enable high quality care, promote equity, and protect patients, the coalition believes legislation or regulations concerning telehealth should meet the following principles:

The following organizations have endorsed these telehealth principles:

 

 

 

SOURCE National Organization for Rare Disorders (NORD)


These press releases may also interest you

at 17:15
The "Whole Genome And Exome Sequencing Markets - By Research, Clinical, Direct to Consumer, AgriBio & Tumor with Executive and Consultant Guides 2020 to 2024" report has been added to ResearchAndMarkets.com's offering. The report forecasts the...

at 17:10
Shionogi & Co., Ltd. (hereafter "Shionogi") today announces that 18 abstracts on FETROJA® (cefiderocol), including two oral presentations, will be shared at IDWeektm. The meeting will be held virtually from October 21-25. "These data reinforce our...

at 17:05
Sage Therapeutics, Inc. , a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain, today announced it will host a live webcast on Thursday,...

at 17:03
NeuPath Health Inc. (formerly Klinik Health Ventures Corp.) ("NeuPath" or the "Company"), Canada's largest provider of chronic pain management services, is pleased to announce that it has entered into an agreement with Stifel GMP as co-lead...

at 16:45
Aptinyx Inc. , a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, today announced positive results from the first Phase 2 study of its novel NMDA receptor modulator,...

at 16:35
Helius Medical Technologies, Inc. ("Helius" or the "Company"), a neurotech company focused on neurological wellness, today announced that it has received a request for additional information from the U.S. Food and Drug Administration (the "FDA" or...



News published on 24 september 2020 at 12:31 and distributed by: